Mrs Brenda II
Metastatic Recurrence Score
About
Calculate breast cancer recurrence risk with ease. Input tumor data to receive a score based on published research. Designed for medical professionals, this tool simplifies risk assessment without requiring patient identifiers.
What's New in Mrs Brenda II
1.0
May 27, 2022
Developer apps
FAQ
What is Mrs Brenda II used for?
Mrs Brenda II is a medical application designed to calculate the metastatic recurrence score for breast cancer patients. It utilizes tumor data to provide a risk assessment based on research published in Cancers 2021.
How accurate is the recurrence score provided by Mrs Brenda II?
The recurrence score is based on the methodology published by Wischnewsky et al. in Cancers 2021. The app itself has a high user rating of 5.0 stars, indicating positive user reception of its functionality.
Does Mrs Brenda II require patient personal information?
No, Mrs Brenda II is designed to protect patient privacy. It does not require patient names or IDs, only the relevant tumor data for the calculation.
What devices is Mrs Brenda II compatible with?
Mrs Brenda II is currently supported on iPhone and iPod devices. It is designed for mobile use, allowing for convenient access to risk assessment tools.
When was Mrs Brenda II last updated?
Mrs Brenda II was last updated on May 27, 2022, with version 1.0. This indicates it is a stable release from that date.
Is Mrs Brenda II suitable for patients to use directly?
The app's description advises patients to consult their physician before making any treatment decisions. It is intended as a tool for medical professionals to aid in risk assessment.
What is the age rating for Mrs Brenda II?
Mrs Brenda II has an age rating of +12. This suggests it is appropriate for users aged 12 and above, considering the medical nature of its content.
Does Mrs Brenda II have ads?
No, Mrs Brenda II does not contain advertisements. The application is free to use and does not display any ads to the user.